Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grap'Sud is a French agro-industrial cooperative group specializing in the development and production of high-quality natural ingredients derived from grape and olive co-products. The company operates a dedicated nutraceutical division that produces standardized extracts rich in polyphenols, anthocyanins, and procyanidins, such as its flagship ExGrape line. These products are widely used in the dietary supplement and functional food industries for their antioxidant and cardiovascular benefits. Beyond nutraceuticals, Grap'Sud is a major European producer of grape-based alcohols, natural tartaric acid, and grape concentrates for the wine and spirits sectors. The group emphasizes sustainable upcycling through a circular economy model, sourcing raw materials from a large network of partner wineries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grap'Sud.